Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Where can I find info about the buyout rumor?
I have a feeling that someone at nasdaq did a little digging to confirm the facts in that article. They don't just copy and paste a PR and slap it on their website.
They don't have to dilute to pay off the debt if they sell 10,000-20,000 units a month! They pay in cash!
It's one institution actually. I forget the name but it's something like green tree investments. I talk to the company regularly. I bet you haven't picked up the phone once
You should contact the company. They will more than reassure you.
The note will be paid off in the first month of sales. It's not a large note at all
Dilution will not happen. The option is with an investment group holding a large number of shares. The company has stated in a recent email chain with several people that they do not believe the investment group will sell any shares. The investment group is "allowed" to start selling shares in September though.
Authorized shares are still 400 MM. nothing has changed. MMJ news early next week.
Nasdaq.com does not publish articles about fake companies
FILINGS RELEASED BY COMPANY REASSURING EVERYONE THAT STOCK BUYBACK IS STILL HAPPENING
http://www.otcmarkets.com/ajax/showFinancialReportById.pdf?id=178024
The next week or two will be the beginning of volume returning to the OTC. Summer is over and kids are going back to school. September is always when volume returns to OTC markets. Be prepared before people start to buy back in to hold for fall and spring
Buys coming in because of MMJ news anticipation this week!
http://m.marketwired.com/press-release/viaderma-inc-set-begin-sales-its-fda-registered-topical-antibiotic-september-with-initial-otc-pink-vdrm-2230725.htm
SOURCE: ViaDerma, Inc.
August 18, 2017 08:00 ET
ViaDerma, Inc. Set to Begin Sales of its FDA Registered Topical Antibiotic in September with Initial Orders from Japan
Viaderma, Inc. announces Galaxy Solutions, Inc. as new sales representative for select Asia Pacific markets
LOS ANGELES, CA--(Marketwired - August 18, 2017) - ViaDerma, Inc. (OTC PINK: VDRM), a specialty pharmaceutical company devoted to bringing new products to market, announced today that it has appointed Galaxy Solutions, Inc. as its sales representative for its first aid topical antibiotic which will be sold under the brand name Vitastem in select markets of Asia Pacific, starting in Japan. The agreement includes sales and marketing responsibilities of the Vitastem brand and possible other brands that will be developed for specific market segments. Galaxy Solutions, Inc. will work to sell directly to larger customers and to distributors and will be the primary provider of service and support in the covered markets.
"With Galaxy Solutions as our sales representative, we will immediately have access to the professional segment of our target markets," said Dr. Chris Otiko, CEO of Viaderma, Inc. "Our goal is to continuously increase our revenues and improve our customers' experience in every aspect. Expanding our network of sales and support personnel and being in close proximity to where our customers are is a key initiative towards achieving that. With competitive pricing for retail sales through doctor's offices in Japan, the Company is conservatively estimating 2018 sales in Japan alone at approximately $12 million US dollars."
"Over the last 7 years Galaxy Solutions has established itself as a premier supplier of epidermal healing solutions, anti-aging solutions and beautification solutions. The relationship with Galaxy Solutions, Inc. will allow us to introduce our products to several markets, initially in Japan and then throughout Asia Pacific, immediately," said Otiko.
"Product testing has already begun and we are expecting to place an initial order in the next 30-45 days. I expect sales to be at around 10,000 units per month in the first 4-6 months and we hope to double that to 20,000 units per month in 2018 in Japan alone. The current testing is being done on sores resulting form side effects of cancer treatments and this will be our initial market, next we expect to introduce a product for acne," said Don Heath, President and CEO of Galaxy Solutions, Inc.
About ViaDerma, Inc.
ViaDerma, Inc. (OTC PINK: VDRM) is a publicly traded specialty pharmaceutical company committed to bringing new products to market and licensing its innovative technology to current leaders in the pharmaceutical industry in a wide variety of therapeutic areas. ViaDerma's products use an innovative transdermal delivery method that allows for application of active ingredients in a topical form. This patent-pending dual carrier transdermal technology may be applied in products within the medical and cosmetic markets. Also, a patent application using the combination of CBD's and THC with the delivery system was filed in 2017. The use of CBD's is for the reduction of inflammation and for the treatment of several diseases, such as, nicotine addiction, fibromyalgia, Cohn's disease, schizophrenia, migraine headaches, pain management for cancer and Multiple Sclerosis. For more information, please visit: www.viadermalicensing.com.
About Galaxy Solutions, Inc.
Galaxy Solutions, Inc. is run by its CEO, Don Heath, a veteran in the area of product positioning and sales. After a successful career developing strategic global sales initiatives for fortune 100 companies in the 1980's, 90's and early 2000's, Don decided that he would move to Japan and set up his own Sales Representation company. Today, Don has developed deep relationships with retailers and distributors throughout Asia Pacific and has introduced many products to the Asia Pacific Market.
I wouldn't doubt it. This will be huge and we are only a week or two away
Yes I was just talking about for 2017 to start off with. 2018 will be 20,000+ a month which is over $1,200,000 in revenue a month
I cannot say this enough. A contract has been signed which means that Galaxy has to buy 10,000 units per month in 2017
You just trade your shares for cash.
Contract is signed and money has been transferred. Vitastem gets shipped to Japan this month
They are not issuing these shares
News releasing this week! The company is responding to everyone's emails in such a way that they are hinting at Marijuana news coming out this week on additional products. MMJ market is about to start ramping up again.
CHART:
CMF shows that accumulation is increasing dramatically and has been up-trending since May. AROON shows us that an upwards trend has begun.
http://stockcharts.com/h-sc/ui
You said this morning that you were going to sell at .026 but woke up too late or somthing like that. You probably do a combination of holding and flipping. I assume you flipped during this run and I suggest you get back in before EOD
This will be in more facilities than just nursing homes. Wound care clinics, emergency rooms, burn centers, demonologists offices, and so on and so on. The list is quite literally almost endless.
It has already sold to a distributor. 10,000 units a month in 2017 and 20,000 units a month in 2018.
I'm not saying this will be over $1 by Christmas but based on the sales contract currently in place we should see $0.20 by December
Biotechs trade at 20-30x revenue. So it will be much higher than 15 Mil
I couldn't have said it better.
I don't think shorters releases a PR about sales
And this run is backed by revenue and not on hype alone like most small cap stocks. This will be a much more stable gain and will likely not crash and burn in a few weeks.
There will be no need for dilution when they get revenue this month. Revenue for 2017 is set for $600,000 a month. This will be paid off with cash from sales, not dilution.
Close near HOD and 45 Million in volume! Incredible!
I've been here a long long long time and have a good relationship with the company. I've done more research on this company than I've ever done in my entire life. I've checked and double checked. This is the stock of a lifetime
Yes definitely no 750 Mil authorized shares. Still remains only 400 Mil
Bye
I would send an email to IR with your phone number and tell them you would like to set up a phone call and he will call you and answer all your questions. His name is rich.
A lot of shorting and impatience.
Don't veer away from your rules of trading but I would highly advise you to keep a small portion of your shares. I promise you it will be worth it
I couldn't agree more. I've never wanted it to be Monday so bad in my life
I would Contact the company instead of searching in here
Once again, the distributor is private. They probably don't release news or anything of the sort. They don't need a website or advertisement etc. If I googled an average persons name who owned a private business I might find their LinkedIn or a yellow pages name and nothing else. Everyone things that every company involved must be available for examination on the internet and that is just not the case in real life. They are also based in Japan which means if they do have a website it will have a Japanese domain and will not end in the typical ".com"